Vital Farms, Inc. (NASDAQ:VITL - Free Report) - Analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for Vital Farms in a note issued to investors on Thursday, November 7th. William Blair analyst J. Andersen now expects that the company will earn $1.08 per share for the year, down from their previous estimate of $1.09. The consensus estimate for Vital Farms' current full-year earnings is $1.10 per share. William Blair also issued estimates for Vital Farms' Q4 2024 earnings at $0.12 EPS and FY2025 earnings at $1.22 EPS.
Other research analysts have also issued reports about the company. Stifel Nicolaus dropped their price objective on Vital Farms from $42.00 to $34.00 and set a "hold" rating for the company in a research note on Friday, August 9th. Jefferies Financial Group dropped their price objective on Vital Farms from $45.00 to $41.00 and set a "buy" rating for the company in a research note on Monday. DA Davidson increased their price objective on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a research note on Thursday, October 10th. Finally, TD Cowen dropped their price objective on Vital Farms from $46.00 to $41.00 and set a "buy" rating for the company in a research note on Friday. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, Vital Farms currently has a consensus rating of "Moderate Buy" and an average price target of $39.20.
Read Our Latest Research Report on VITL
Vital Farms Stock Performance
VITL stock traded down $1.63 during midday trading on Monday, hitting $29.28. The stock had a trading volume of 2,387,779 shares, compared to its average volume of 783,857. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 26.14 and a beta of 0.97. Vital Farms has a 52 week low of $11.72 and a 52 week high of $48.41. The stock has a 50-day simple moving average of $34.96 and a 200 day simple moving average of $36.74. The company has a current ratio of 3.50, a quick ratio of 3.03 and a debt-to-equity ratio of 0.04.
Vital Farms (NASDAQ:VITL - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported $0.16 EPS for the quarter, topping the consensus estimate of $0.14 by $0.02. The firm had revenue of $145.00 million during the quarter, compared to analysts' expectations of $145.27 million. Vital Farms had a return on equity of 23.29% and a net margin of 8.68%. Vital Farms's quarterly revenue was up 31.3% compared to the same quarter last year. During the same period last year, the business earned $0.10 earnings per share.
Hedge Funds Weigh In On Vital Farms
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in VITL. Lord Abbett & CO. LLC boosted its holdings in Vital Farms by 116.1% during the first quarter. Lord Abbett & CO. LLC now owns 862,644 shares of the company's stock worth $20,056,000 after buying an additional 463,471 shares during the last quarter. Millennium Management LLC boosted its holdings in Vital Farms by 651.3% during the second quarter. Millennium Management LLC now owns 494,153 shares of the company's stock worth $23,112,000 after buying an additional 428,382 shares during the last quarter. Emerald Advisers LLC boosted its holdings in Vital Farms by 106.8% during the third quarter. Emerald Advisers LLC now owns 706,440 shares of the company's stock worth $24,775,000 after buying an additional 364,837 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in Vital Farms by 73.0% during the second quarter. Renaissance Technologies LLC now owns 784,153 shares of the company's stock worth $36,675,000 after buying an additional 331,000 shares during the last quarter. Finally, Acadian Asset Management LLC lifted its holdings in shares of Vital Farms by 73.6% during the 2nd quarter. Acadian Asset Management LLC now owns 679,504 shares of the company's stock valued at $31,766,000 after purchasing an additional 288,039 shares in the last quarter. Institutional investors own 98.59% of the company's stock.
Insider Activity
In other news, CEO Russell Diez-Canseco sold 44,653 shares of the firm's stock in a transaction on Monday, October 14th. The stock was sold at an average price of $40.07, for a total value of $1,789,245.71. Following the completion of the sale, the chief executive officer now directly owns 537,349 shares in the company, valued at approximately $21,531,574.43. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, insider Matthew Ohayer sold 24,000 shares of the firm's stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $39.09, for a total value of $938,160.00. Following the transaction, the insider now owns 7,194,777 shares in the company, valued at $281,243,832.93. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Russell Diez-Canseco sold 44,653 shares of the firm's stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $40.07, for a total value of $1,789,245.71. Following the completion of the transaction, the chief executive officer now owns 537,349 shares in the company, valued at approximately $21,531,574.43. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 27.60% of the stock is currently owned by corporate insiders.
Vital Farms Company Profile
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
See Also
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.